Identifying the profile of Helicobacter pylori negative gastric cancers: a case only analysis within the Stomach cancer Pooling (StoP) Project.

BACKGROUND The prevalence of Helicobacter pylori negative gastric cancer (HpNGC) can be as low as 1%, when infection is assessed using more sensitive tests or considering the presence of gastric atrophy. HpNGC may share a high-risk profile contributing to the occurrence of cancer in the absence of infection. We estimated the proportion of HpNGC, using different criteria to define infection status, and compared HpNGC and positive cases regarding gastric cancer risk factors. METHODS Cases from 12 studies from the Stomach cancer Pooling (StoP) Project providing data on H. pylori infection status determined by serological test were included. HpNGC was reclassified as positive (eight studies) when cases presented CagA markers (four studies), gastric atrophy (six studies), or advanced stage at diagnosis (three studies), and were compared with positive cases. A two-stage approach (random-effects models) was used to pool study-specific prevalence and adjusted odds ratios (ORs). RESULTS Among non-cardia cases, the pooled prevalence of HpNGC was 22.4% (n=166/853) and decreased to 7.0% (n=55) when considering CagA status; estimates for all criteria were 21.8% (n=276/1325) and 6.6% (n=97), respectively. HpNGC had a family history of gastric cancer more often (OR=2.18, 95% confidence interval [CI]:1.03-4.61) and were current smokers (OR=2.16, 95%CI:0.52-9.02). CONCLUSION This study found a low prevalence of HpNGC, who are more likely to have a family history of gastric cancer in first-degree relatives. IMPACT Our results support that H. pylori infection is present in most non-cardia gastric cancers, and suggest that HpNGC may have distinct patterns of exposure to other risk factors.

[1]  Low Prevalence , 2020, Definitions.

[2]  J. Ferlay,et al.  Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. , 2019, The Lancet. Global health.

[3]  R. Malekzadeh,et al.  Education and gastric cancer risk—An individual participant data meta‐analysis in the StoP project consortium , 2019, International journal of cancer.

[4]  R. Malekzadeh,et al.  Alcohol intake and gastric cancer: Meta-analyses of published data versus individual participant data pooled analyses (StoP Project). , 2018, Cancer epidemiology.

[5]  R. Malekzadeh,et al.  Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data (StoP Project) , 2018, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[6]  G. Lee,et al.  Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology , 2018, PloS one.

[7]  R. Malekzadeh,et al.  Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) Project , 2016, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  V. Folkmanis,et al.  Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays , 2017, Helicobacter.

[9]  C. Hamashima,et al.  Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests , 2017, BMC Cancer.

[10]  Sang Kil Lee Do We Need to Retest of Helicobacter pylori Infection after Gastric Cancer Surgery? , 2017, Gut and liver.

[11]  Yuan Yuan,et al.  MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori , 2017, Scientific Reports.

[12]  Hsiu‐Po Wang,et al.  Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer , 2015, PloS one.

[13]  K. Chayama,et al.  Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study , 2017, Gastric Cancer.

[14]  Jeong Ho Kim,et al.  Must-Have Knowledge about the Helicobacter pylori-Negative Gastric Cancer , 2016, Gut and liver.

[15]  Y. Yamaoka,et al.  Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation , 2016, BioMed research international.

[16]  J. Y. Lee,et al.  Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers , 2015, Gut and liver.

[17]  R. Hiatt,et al.  Socioeconomic position in childhood and cancer in adulthood: a rapid-review , 2015, Journal of Epidemiology & Community Health.

[18]  BarretoZuiga Rafael,et al.  Gastric cancer progression associated with local humoral immune responses , 2015, BMC Cancer.

[19]  M. Igarashi,et al.  Helicobacter pylori‐negative gastric cancer: Characteristics and endoscopic findings , 2015, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[20]  Vicente Martín,et al.  Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. , 2015, Gaceta sanitaria.

[21]  R. Malekzadeh,et al.  The stomach cancer pooling (StoP) project: study design and presentation , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  B. Peleteiro,et al.  Tobacco smoking and intestinal metaplasia: Systematic review and meta-analysis. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  I. Choi,et al.  Characteristics of gastric cancer according to Helicobacter pylori infection status , 2014, Journal of gastroenterology and hepatology.

[24]  J. Y. Lee,et al.  Correlations Among Endoscopic, Histologic and Serologic Diagnoses for the Assessment of Atrophic Gastritis , 2014, Journal of cancer prevention.

[25]  O. Uthman,et al.  Socioeconomic position and incidence of gastric cancer: a systematic review and meta-analysis , 2013, Journal of Epidemiology & Community Health.

[26]  Mingzhe Lin,et al.  Prostate stem cell antigen rs2294008 polymorphism differentially contributes to Helicobacter pylori-negative gastric cancer among various populations in China. , 2013, Molecular and clinical oncology.

[27]  K. Chayama,et al.  Low Prevalence of Helicobacter pylori‐negative Gastric Cancer among Japanese , 2011, Helicobacter.

[28]  Nayoung Kim,et al.  Helicobacter pylori‐Negative Gastric Cancer in South Korea: Incidence and Clinicopathologic Characteristics , 2011, Helicobacter.

[29]  C. la Vecchia,et al.  Factors contributing to the underestimation of Helicobacter pylori-associated gastric cancer risk in a high-prevalence population , 2010, Cancer Causes & Control.

[30]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[31]  S. Jo,et al.  Negative Helicobacter pylori Status Is Associated with Poor Prognosis in Patients with Gastric Cancer. (Cancer 2009;115:2071-2080) , 2010 .

[32]  H. Brenner,et al.  Inverse association between a pro-inflammatory genetic profile and Helicobacter pylori seropositivity among patients with chronic atrophic gastritis: enhanced elimination of the infection during disease progression? , 2009, European journal of cancer.

[33]  R. Malekzadeh,et al.  The role of diet and other environmental factors in the causation of gastric cancer in Iran—A population based study , 2009, International journal of cancer.

[34]  L. Oñate-Ocaña,et al.  Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City , 2009, International journal of cancer.

[35]  F. Roviello,et al.  Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer , 2009, Cancer.

[36]  T. Hattori,et al.  Re-evaluation of Histogenesis of Gastric Carcinomas: A Comparative Histopathological Study Between Helicobacter pylori-Negative and H. pylori-Positive Cases , 2009, Digestive Diseases and Sciences.

[37]  E. Tahara Abnormal Growth Factor/Cytokine Network in Gastric Cancer , 2008, Cancer Microenvironment.

[38]  R. Malekzadeh,et al.  Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer , 2007, Gut.

[39]  N. Lunet,et al.  Smoking and gastric cancer: systematic review and meta-analysis of cohort studies , 2008, Cancer Causes & Control.

[40]  M. Inoue,et al.  Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: A nested case-control study using IgG titer against Hp surface antigen , 2008, Acta oncologica.

[41]  P. Correa,et al.  Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.

[42]  Y. Sugisaki,et al.  Helicobacter pylori infection‐negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics , 2007, Cancer science.

[43]  Vittorio Krogh,et al.  Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. , 2006, American journal of epidemiology.

[44]  Gary H Lyman,et al.  The strengths and limitations of meta-analyses based on aggregate data , 2005, BMC Medical Research Methodology.

[45]  M. Inoue,et al.  Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan , 2004, Gastric Cancer.

[46]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[47]  Ming-Rong Wang,et al.  GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population , 2001, Cancer Causes & Control.

[48]  D. Zaridze,et al.  Alcohol Consumption, Smoking and Risk of Gastric Cancer: Case—Control Study from Moscow, Russia , 2000, Cancer Causes & Control.

[49]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[50]  E. Tahara Genetic pathways of two types of gastric cancer. , 2004, IARC scientific publications.

[51]  A. Blair,et al.  Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico , 2003, International journal of cancer.

[52]  S. Tsugane,et al.  Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. , 2002, Japanese journal of clinical oncology.

[53]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[54]  S. Tsugane,et al.  Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in São Paulo. , 2002, Japanese journal of clinical oncology.

[55]  E. Kuipers,et al.  Colonisation density and topographic localisation of Helicobacter pylori do not depend on the cagA status. , 2001, Journal of clinical pathology.

[56]  L. Brown Helicobacter pylori: epidemiology and routes of transmission. , 2000, Epidemiologic reviews.

[57]  L. Hansson,et al.  Tobacco, alcohol and the risk of gastric cancer by sub‐site and histologic type , 1999, International journal of cancer.

[58]  M A Fujino,et al.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations , 1999, Gut.

[59]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[60]  J. Fraumeni,et al.  Cigarette smoking and other risk factors for progression of precancerous stomach lesions. , 1992, Journal of the National Cancer Institute.

[61]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[62]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[63]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[64]  B D PETROV,et al.  In Japan … , 1975, Sovetskoe zdravookhranenie.